| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |